J.H.M. Driessen

Uitgebreid profiel is alleen beschikbaar in Engels.

Schene, M. R., Willems, H. C., Driessen, J. H. M., Vranken, L., Heersprink, F. O. L., Janzing, H. M. J., van der Velde, R. Y., van den Bergh, J. P., & Wyers, C. E. (2024). Physical performance and sarcopenia assessment in patients with a recent fracture visiting the Fracture Liaison Service. Osteoporosis International, 35(5), 851-862. https://doi.org/10.1007/s00198-023-07009-w
Meer informative over deze publicatie
Gulikers, J. L., Veerman, G. D. M., Jebbink, M., Kruithof, P. D., Steendam, C. M. J., Boosman, R. J., Mathijssen, R. H. J., Tjan-Heijnen, V. C. G., Driessen, J. H. M., Dursun, S., Smit, E. F., Dingemans, A. M. C., van Geel, R. M. J. M., Croes, S., & Hendriks, L. E. L. (2024). Osimertinib Plasma Trough Concentration in Relation to Brain Metastases Development in Patients With Advanced EGFR-Mutated NSCLC. JTO Clinical and Research Reports, 5(4), Article 100656. https://doi.org/10.1016/j.jtocrr.2024.100656
Meer informative over deze publicatie
Werkman, N. C. C., García-Sáez, G., Nielen, J. T. H., Tapia-Galisteo, J., Somolinos-Simón, F. J., Hernando, M. E., Wang, J., Jiu, L., Goettsch, W. G., van der Kallen, C. J. H., Koster, A., Schalkwijk, C. G., de Vries, H., de Vries, N. K., Eussen, S. J. P. M., Driessen, J. H. M., & Stehouwer, C. D. A. (2024). Disease severity-based subgrouping of type 2 diabetes does not parallel differences in quality of life: the Maastricht Study. Diabetologia, 67(4), 690-702. https://doi.org/10.1007/s00125-023-06082-4
Meer informative over deze publicatie
Schene, M. R., Wyers, C. E., Driessen, J. H. M., Vranken, L., Meijer, K., van den Bergh, J. P., & Willems, H. C. (2024). The "Can Do, Do Do" Framework Applied to Assess the Association between Physical Capacity, Physical Activity and Prospective Falls, Subsequent Fractures, and Mortality in Patients Visiting the Fracture Liaison Service. Journal of Personalized Medicine, 14(4), Article 337. https://doi.org/10.3390/jpm14040337
Meer informative over deze publicatie
Schene, M. R., Bevers, M. S. A. M., van der Vijgh, W. J. F., Driessen, J. H. M., Vranken, L., van der Velde, R. Y., Willems, H. C., Wyers, C. E., & van den Bergh, J. P. (2024). PPI use is not associated with bone microarchitecture and strength assessed with HR-pQCT after three-years follow-up in patients visiting the Fracture Liaison Service. Bone, 182, Article 117066. https://doi.org/10.1016/j.bone.2024.117066
Meer informative over deze publicatie
Rasmussen, N. H., Driessen, J. H. M., Kvist, A. V., Souverein, P. C., van den Bergh, J. P., & Vestergaard, P. (2024). Fracture patterns and associated risk factors in pediatric and early adulthood type 1 diabetes: Findings from a nationwide retrospective cohort study. Bone, 180, Article 116997. https://doi.org/10.1016/j.bone.2023.116997
Meer informative over deze publicatie
Rasmussen, N. H., Driessen, J. H. M., Kvist, A. V., Souverein, P. C., van den Bergh, J., & Vestergaard, P. (2024). Fracture patterns in adult onset type 1 diabetes and associated risk factors - A nationwide cohort study. Bone, 179, Article 116977. https://doi.org/10.1016/j.bone.2023.116977
Meer informative over deze publicatie
van Veelen, A., Veerman, G. D. M., Verschueren, M. V., Gulikers, J. L., Steendam, C. M. J., Brouns, A. J. W. M., Dursun, S., Paats, M. S., Tjan-Heijnen, V. C. G., van der Leest, C., Dingemans, A.-M. C., Mathijssen, R. H. J., van de Garde, E. M. W., Souverein, P., Driessen, J. H. M., Hendriks, L. E. L., van Geel, R. M. J. M., & Croes, S. (2024). Exploring the impact of patient-specific clinical features on osimertinib effectiveness in a real-world cohort of patients with EGFR mutated non-small cell lung cancer. International Journal of Cancer, 154(2), 332-342. https://doi.org/10.1002/ijc.34742
Meer informative over deze publicatie
van Hulten, V., Driessen, J. H. M., Starup-Linde, J. K., Al-Mashhadi, Z. K., Viggers, R., Klungel, O. H., Souverein, P. C., Vestergaard, P., Stehouwer, C. D. A., & van den Bergh, J. P. (2023). The associations of sodium-glucose cotransporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors as add-on to metformin with fracture risk in patients with type 2 diabetes mellitus. Diabetes Obesity & Metabolism, 25(11), 3235-3247. https://doi.org/10.1111/dom.15220
Meer informative over deze publicatie
Schene, M. R., Wyers, C. E., Driessen, A. M. H., Souverein, P. C., Gemmeke, M., van den Bergh, J. P., & Willems, H. C. (2023). Imminent fall risk after fracture. Age and Ageing, 52(10), 1-9. Article afad201. https://doi.org/10.1093/ageing/afad201
Meer informative over deze publicatie

Ga naar alle publicaties

J.H.M. Driessen

Researcher

Klinische Farmacie

School for Cardiovascular Diseases

Fac. Health, Medicine and Life Sciences

Zoekterm

J.H.M. Driessen

Recente publicaties lees meer

J.H.M. Driessen